Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

Queensland Life Sciences Industry Report 2012
78
12.1.4 Market Entry
All respondents who export goods or services were asked to select from five possible market entry options. Companies (55)
nominated a total of 80 market entry options with the most commonly selected option being the export of finished product
(53%). Research organisations (7) nominated ten market entry options with the most commonly selected option being the
export of services (70%) (Figure 48).
Apart from the five reasons offered in the survey, there were six ‘Other’ reasons given including export of raw ingredients;
export of data, specimens, and samples; via networks collaborations and alliances; and through installing an offshore
business development appointee.
Figure 48: Export market entry options (62 respondents)
12.2 International Business Deals, Research Collaborations & Alliances
12.2.1 Revenue from International Business Deals
42 of 100 (42%) companies reported earning revenue from international business deals or research collaborations.
An average of 32% (median 20%) of revenue was derived from international business deals and collaborations.
12.2.2 Current Markets for International Business Deals and Collaborations
Of all the international business deals and collaborations reported by respondents, 69% were international business deals
and 31% were research collaborations. In 2009 and 2011 both were most commonly located in the USA.
Figure 49: International business deals and research collaborations by region